Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by canon12345on Jan 14, 2021 11:32am
316 Views
Post# 32294283

Steps forward and still needed

Steps forward and still neededWhile Dr. Adams has made some strides since the new VMS 3.0 came out there is one major step the company needs to take to propel the stock to much higher levels. We all know that is a substantial Sales order from one of these hospitals ie: MD Anderson or perhaps the Kings College Hospital in London or other top notch facility. Having Chinese interest in the stock also is interesting as this is also the possibility for a large order from China. Dr. Adams also had the foresite to see the market possibilities in the Veterinary space. Far to early to say how this will go but is still a shrewd move and could lead to a secondary or perhaps far larger market then previously thought for the 3.0. The ground work is actually quite impressive in the past few months but we need that large order and several more if this stock is going to go to the heights some of us here believe it will.    

<< Previous
Bullboard Posts
Next >>